A Double-blind, Randomized, Placebo-controlled, Multicenter Study to Assess the Efficacy and Safety of Omecamtiv Mecarbil on Mortality and Morbidity in Subjects with Chronic Heart Failure with Reduced
Administered By
Awarded By
Contributors
- Felker, Gary Michael Principal Investigator
Start/End
- August 4, 2016 - February 21, 2021